Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Inter-ethnic differences in lymphocyte sensitivity to glucocorticoids reflect variation in transcriptional response

The Pharmacogenomics Journal volume 13, pages 121–129 (2013)Cite this article

Subjects

Abstract

Glucocorticoids (GCs) are steroid hormones widely used as pharmaceutical interventions, which act mainly by regulating gene expression levels. A large fraction of patients (∼30%), especially those of African descent, show a weak response to treatment. To interrogate the contribution of variable transcriptional response to inter-ethnic differences, we measured in vitro lymphocyte GC sensitivity (LGS) and transcriptome-wide response to GCs in peripheral blood mononuclear cells from African–American (AA) and European–American (EA) healthy donors. We found that transcriptional response after 8 h treatment was significantly correlated with variation in LGS within and between populations. We found that NFKB1, a gene previously found to predict LGS within populations, was more strongly downregulated in EAs on average. NFKB1 could not completely explain population differences, however, and we found an additional 177 genes with population differences in the average log2 fold change (false discovery rate<0.05), most of which also showed a weaker transcriptional response in AAs. These results suggest that inter-ethnic differences in GC sensitivity reflect variation in transcriptional response at many genes, including regulators with large effects (for example, NFKB1) and numerous other genes with smaller effects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Verini M, Rossi N, Dalfino T, Verrotti A, Di Gioacchino M, Chiarelli F . Lack of correlation between clinical patterns of asthma and airway obstruction. Allergy Asthma Proc 2001; 22: 297–302.

    CAS  PubMed  Google Scholar 

  2. NHLBI. Highlights of the Expert Panel Report 2: Guidelines for Diagnosis and Management of Asthma. NIH Publications: Bethesda, MD, 1997. p. 50.

  3. Chung KF, O’Byrne P . Pharmacological agents used to treat asthma. In: Fabbri LM, (ed). Asthma. European Respiratory Society Journals: Sheffield, 2003 pp. 339–375.

    Google Scholar 

  4. Inaba H, Pui CH . Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 2010; 11: 1096–1106.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. van der Laan S, Meijer OC . Pharmacology of glucocorticoids: beyond receptors. Eur J Pharmacol 2008; 585: 483–491.

    Article  CAS  PubMed  Google Scholar 

  6. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109: 410–418.

    Article  CAS  PubMed  Google Scholar 

  7. Drazen JM, Silverman EK, Lee TH . Heterogeneity of therapeutic responses in asthma. Br Med Bull 2000; 56: 1054–1070.

    Article  CAS  PubMed  Google Scholar 

  8. Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999; 130: 487–495.

    Article  CAS  PubMed  Google Scholar 

  9. Chan MT, Leung DY, Szefler SJ, Spahn JD . Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol 1998; 101: 594–601.

    Article  CAS  PubMed  Google Scholar 

  10. Duffy DL, Martin NG, Battistutta D, Hopper JL, Mathews JD . Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 1990; 142 (6 Part 1): 1351–1358.

    Article  CAS  PubMed  Google Scholar 

  11. Hearing SD, Norman M, Smyth C, Foy C, Dayan CM . Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab 1999; 84: 4149–4154.

    CAS  PubMed  Google Scholar 

  12. Mattano Jr LA, Sather HN, Trigg ME, Nachman JB . Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 2000; 18: 3262–32672.

    Article  PubMed  Google Scholar 

  13. Weiss ST, Lake SL, Silverman ES, Silverman EK, Richter B, Drazen JM et al. Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses. Proc Am Thorac Soc 2004; 1: 364–367.

    Article  CAS  PubMed  Google Scholar 

  14. Gould W, Peterson EL, Karungi G, Zoratti A, Gaggin J, Toma G et al. Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma. J Allergy Clin Immunol 2010; 126: 1131–1138.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Corrigan CJ, Bungre JK, Assoufi B, Cooper AE, Seddon H, Kay AB . Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents. Eur Respir J 1996; 9: 2077–2086.

    Article  CAS  PubMed  Google Scholar 

  16. Haczku A, Alexander A, Brown P, Assoufi B, Li B, Kay AB et al. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol 1994; 93: 510–519.

    Article  CAS  PubMed  Google Scholar 

  17. Alvarez J, Surs W, Leung DY, Ikle D, Gelfand EW, Szefler SJ . Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 1992; 89: 714–721.

    Article  CAS  PubMed  Google Scholar 

  18. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai JJ, Frew AJ et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991; 144: 1016–1025.

    Article  CAS  PubMed  Google Scholar 

  19. Poznansky MC, Gordon AC, Douglas JG, Krajewski AS, Wyllie AH, Grant IW . Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin Sci (Lond) 1984; 67: 639–645.

    Article  CAS  Google Scholar 

  20. Kirkham BW, Corkill MM, Davison SC, Panayi GS . Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses. J Rheumatol 1991; 18: 821–825.

    CAS  PubMed  Google Scholar 

  21. Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J et al. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 823–830.

    Article  CAS  PubMed  Google Scholar 

  22. Langhoff E, Ladefoged J, Jakobsen BK, Platz P, Ryder LP, Svejgaard A et al. Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival. Lancet 1986; 1: 1296–1297.

    Article  CAS  PubMed  Google Scholar 

  23. Federico MJ, Covar RA, Brown EE, Leung DY, Spahn JD . Racial differences in T-lymphocyte response to glucocorticoids. Chest 2005; 127: 571–578.

    Article  CAS  PubMed  Google Scholar 

  24. Akinbami LJ, Schoendorf KC . Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002; 110 (2 Part 1): 315–322.

    Article  PubMed  Google Scholar 

  25. Grant EN, Lyttle CS, Weiss KB . The relation of socioeconomic factors and racial/ethnic differences in US asthma mortality. Am J Public Health 2000; 90: 1923–1925.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Joseph CL, Ownby DR, Peterson EL, Johnson CC . Racial differences in physiologic parameters related to asthma among middle-class children. Chest 2000; 117: 1336–1344.

    Article  CAS  PubMed  Google Scholar 

  27. Boldizsar F, Talaber G, Szabo M, Bartis D, Palinkas L, Nemeth P et al. Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells. Immunobiology 2010; 215: 521–526.

    Article  CAS  PubMed  Google Scholar 

  28. Stahn C, Buttgereit F . Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol 2008; 4: 525–533.

    Article  CAS  PubMed  Google Scholar 

  29. Ray A, Prefontaine KE . Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994; 91: 752–756.

    Article  CAS  PubMed  Google Scholar 

  30. Rogatsky I, Ivashkiv LB . Glucocorticoid modulation of cytokine signaling. Tissue Antigens 2006; 68: 1–12.

    Article  CAS  PubMed  Google Scholar 

  31. Hakonarson H, Bjornsdottir US, Halapi E, Bradfield J, Zink F, Mouy M et al. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc Natl Acad Sci USA 2005; 102: 14789–14794.

    Article  CAS  PubMed  Google Scholar 

  32. Du P, Kibbe WA, Lin SM . lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24: 1547–1548.

    Article  CAS  PubMed  Google Scholar 

  33. Lin SM, Du P, Huber W, Kibbe WA . Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 2008; 36: e11.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Smyth GK . Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article3.

    Article  Google Scholar 

  35. Storey JD, Tibshirani R . Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440–9445.

    Article  CAS  PubMed  Google Scholar 

  36. Huang da W, Sherman BT, Lempicki RA . Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44–57.

    Article  PubMed  Google Scholar 

  37. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4: P3.

    Article  PubMed  Google Scholar 

  38. Ayroldi E, Riccardi C . Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 2009; 23: 3649–3658.

    Article  CAS  PubMed  Google Scholar 

  39. Luca F, Kashyap S, Southard C, Zou M, Witonsky D, Di Rienzo A et al. Adaptive variation regulates the expression of the human SGK1 gene in response to stress. PLoS Genet 2009; 5: e1000489.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Habib-Agahi M, Phan TT, Searle PF . Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells. Int Immunol 2007; 19: 1383–1394.

    Article  CAS  PubMed  Google Scholar 

  41. Maranville JC, Luca F, Richards AL, Wen X, Witonsky DB, Baxter S et al. Interactions between Glucocorticoid Treatment and Cis-Regulatory Polymorphisms Contribute to Cellular Response Phenotypes. PLoS Genet 2011; 7: e1002162.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Grundberg E, Adoue V, Kwan T, Ge B, Duan QL, Lam KC et al. Global analysis of the impact of environmental perturbation on cis-regulation of gene expression. PLoS Genet 2011; 7: e1001279.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Ding J, Gudjonsson JE, Liang L, Stuart PE, Li Y, Chen W et al. Gene expression in skin and lymphoblastoid cells: Refined statistical method reveals extensive overlap in cis-eQTL signals. Am J Hum Genet 2010; 87: 779–789.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Raychaudhuri S, Stuart JM, Altman RB . Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput 2000; 5: 455–466.

    Google Scholar 

  45. Bisset LR, Schmid-Grendelmeier P . Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med 2005; 11: 35–42.

    Article  CAS  PubMed  Google Scholar 

  46. Harhaj EW, Dixit VM . Deubiquitinases in the regulation of NF-kappaB signaling. Cell Res 2011; 21: 22–39.

    Article  CAS  PubMed  Google Scholar 

  47. Hershko DD . Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target. Future Oncol 2010; 6: 1837–1847.

    Article  CAS  PubMed  Google Scholar 

  48. Barnes MJ, Aksoylar H, Krebs P, Bourdeau T, Arnold CN, Xia Y et al. Loss of T cell and B cell quiescence precedes the onset of microbial flora-dependent wasting disease and intestinal inflammation in Gimap5-deficient mice. J Immunol 2010; 184: 3743–3754.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170: 836–844.

    Article  PubMed  Google Scholar 

  50. Schwartz JT, Reuling FH, Feinleib M, Garrison RJ, Collie DJ . Twin heritability study of the effect of corticosteroids on intraocular pressure. J Med Genet 1972; 9: 137–143.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Bray PJ, Cotton RG . Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum Mutat 2003; 21: 557–568.

    Article  CAS  PubMed  Google Scholar 

  52. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 1998; 83: 144–151.

    CAS  PubMed  Google Scholar 

  53. Kumsta R, Moser D, Streit F, Koper JW, Meyer J, Wust S . Characterization of a glucocorticoid receptor gene (GR, NR3C1) promoter polymorphism reveals functionality and extends a haplotype with putative clinical relevance. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 476–482.

    Article  CAS  PubMed  Google Scholar 

  54. Hawkins GA, Lazarus R, Smith RS, Tantisira KG, Meyers DA, Peters SP et al. The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. J Allergy Clin Immunol 2009; 123: 1376–1383, e7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004; 13: 1353–1359.

    Article  CAS  PubMed  Google Scholar 

  56. Cole SW, Hawkley LC, Arevalo JM, Sung CY, Rose RM, Cacioppo JT . Social regulation of gene expression in human leukocytes. Genome Biol 2007; 8: R189.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Bower JE, Ganz PA, Irwin MR, Arevalo JM, Cole SW . Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun 2011; 25: 147–150.

    Article  CAS  PubMed  Google Scholar 

  58. Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, Campana D et al. Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 2011; 43: 237–241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Caliskan M, Cusanovich DA, Ober C, Gilad Y . The effects of EBV transformation on gene expression levels and methylation profiles. Hum Mol Genet 2011; 20: 1643–1652.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank T Gajewski and Y Zha at the Human Immunological Monitoring facility for helpful discussions about experimental protocols and study design. JCM was supported by an American Heart Association pre-doctoral fellowship (#11PRE4960001). This work was funded by the NIH Grants DK-56670 and DK-56670-S1 to AD. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Human Genetics, The University of Chicago, Chicago, IL, USA

    J C Maranville, S S Baxter, J M Torres & A Di Rienzo

Authors
  1. J C Maranville
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S S Baxter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J M Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Di Rienzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Di Rienzo.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maranville, J., Baxter, S., Torres, J. et al. Inter-ethnic differences in lymphocyte sensitivity to glucocorticoids reflect variation in transcriptional response. Pharmacogenomics J 13, 121–129 (2013). https://doi.org/10.1038/tpj.2011.55

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2011.55

Keywords

This article is cited by

Search

Advanced search

Quick links